• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

牛因子VIII的一种肽组分在实验动物中使出血时间缩短。

Decrease of bleeding time by a peptide fraction from bovine factor VIII in laboratory animals.

作者信息

Gervasi G B, Bartoli C, Carpita G, Baldacci M

机构信息

Baldacci Research Laboratories, Pisa, Italy.

出版信息

Arzneimittelforschung. 1988 Sep;38(9):1268-70.

PMID:3146984
Abstract

A peptide fraction of low molecular weight prepared from bovine Factor VIII by enzymatic hydrolysis (Vueffe) reduces bleeding time in laboratory animals. In this study the haemostatic action in mice, rats and rabbits was investigated using different experimental conditions. This action was observed in animals with either normal or experimentally prolonged bleeding time, thus suggesting better efficacy in pathological situations. The evidence obtained following different routes of administration confirmed the activity of the compound. The efficacy was present at very low doses in all animal species without interfering either with platelets or with blood coagulation.

摘要

通过酶解(Vueffe)从牛因子VIII制备的低分子量肽级分可缩短实验动物的出血时间。在本研究中,使用不同的实验条件研究了其在小鼠、大鼠和兔子中的止血作用。在出血时间正常或经实验延长的动物中均观察到了这种作用,这表明在病理情况下该肽级分具有更好的疗效。通过不同给药途径获得的证据证实了该化合物的活性。在所有动物物种中,该肽级分在非常低的剂量下就具有疗效,且不影响血小板或血液凝固。

相似文献

1
Decrease of bleeding time by a peptide fraction from bovine factor VIII in laboratory animals.牛因子VIII的一种肽组分在实验动物中使出血时间缩短。
Arzneimittelforschung. 1988 Sep;38(9):1268-70.
2
[A pharmacological and clinical review on the activity of a bovine factor VIII derivative obtained by enzymatic hydrolysis].[关于一种通过酶解获得的牛因子VIII衍生物活性的药理学与临床综述]
Clin Ter. 1989 Feb 28;128(4):271-90.
3
Absorption and excretion in the experimental animal of a 14C-ethylmaleimide labelled peptide fraction of bovine factor VIII with antihaemorrhagic activity.具有抗出血活性的牛因子VIII的14C-乙基马来酰亚胺标记肽段在实验动物中的吸收与排泄。
Arzneimittelforschung. 1989 Apr;39(4):463-6.
4
Effects of a low molecular weight heparin (Fragmin) and of unfractionated heparin on coagulation activation at the site of plug formation in vivo.低分子量肝素(速碧林)与普通肝素对体内血栓形成部位凝血激活的影响。
Thromb Haemost. 1994 Dec;72(6):831-5.
5
Slight differences in sulfation of algal galactans account for differences in their anticoagulant and venous antithrombotic activities.藻类半乳聚糖硫酸化的细微差异导致其抗凝和静脉抗血栓活性存在差异。
Thromb Haemost. 2008 Mar;99(3):539-45. doi: 10.1160/TH07-10-0603.
6
Characterization of a form of bovine factor VIII which does not aggregate human platelets.
Thromb Haemost. 1981 Aug 28;46(2):479-84.
7
Cutaneous and systemic effects of varying doses of brown recluse spider venom in a rabbit model.不同剂量棕色遁蛛毒液在兔模型中的皮肤和全身效应
Clin Lab Sci. 2007 Spring;20(2):99-105.
8
Arterial antithrombotic effects of aspirin, heparin, enoxaparin and clopidogrel alone, or in combination, in the rat.阿司匹林、肝素、依诺肝素和氯吡格雷单独或联合使用对大鼠的动脉抗血栓作用。
Thromb Res. 2006;118(6):755-62. doi: 10.1016/j.thromres.2005.11.015. Epub 2006 Jan 10.
9
Fucosylated chondroitin sulfate as a new oral antithrombotic agent.岩藻糖基化硫酸软骨素作为一种新型口服抗血栓药物。
Thromb Haemost. 2006 Dec;96(6):822-9.
10
Interaction of the 268-282 region of glycoprotein Ibalpha with the heparin-binding site of thrombin inhibits the enzyme activation of factor VIII.糖蛋白Iα的268 - 282区域与凝血酶的肝素结合位点之间的相互作用会抑制因子VIII的酶激活。
Biochem J. 2003 Jul 15;373(Pt 2):593-601. doi: 10.1042/BJ20030167.